SE8105561L - Anvendning av pyridoxin-alfa-ketoglutarat vid profylax av hypermjolksyraemi - Google Patents

Anvendning av pyridoxin-alfa-ketoglutarat vid profylax av hypermjolksyraemi

Info

Publication number
SE8105561L
SE8105561L SE8105561A SE8105561A SE8105561L SE 8105561 L SE8105561 L SE 8105561L SE 8105561 A SE8105561 A SE 8105561A SE 8105561 A SE8105561 A SE 8105561A SE 8105561 L SE8105561 L SE 8105561L
Authority
SE
Sweden
Prior art keywords
ketoglutarate
hypermoolic
acidema
prophylax
pyridoxin
Prior art date
Application number
SE8105561A
Other languages
English (en)
Swedish (sv)
Other versions
SE459899B (sv
Inventor
F Fici
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of SE8105561L publication Critical patent/SE8105561L/
Publication of SE459899B publication Critical patent/SE459899B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8105561A 1980-09-22 1981-09-21 Anvaendning av pyridoxin - - ketoglutarat foer framstaellning av en farmaceutisk komposition foer profylax av hypermjoelksyraemi SE459899B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24827/80A IT1141070B (it) 1980-09-22 1980-09-22 Impiego dell'alfa-chetoglutarato di piridossina nella profilassi della iperlattacidemia

Publications (2)

Publication Number Publication Date
SE8105561L true SE8105561L (sv) 1982-03-23
SE459899B SE459899B (sv) 1989-08-21

Family

ID=11214855

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8105561A SE459899B (sv) 1980-09-22 1981-09-21 Anvaendning av pyridoxin - - ketoglutarat foer framstaellning av en farmaceutisk komposition foer profylax av hypermjoelksyraemi

Country Status (12)

Country Link
US (1) US4361570A ( )
JP (1) JPS5782316A ( )
BE (1) BE890454A ( )
CA (1) CA1177408A ( )
CH (1) CH655009A5 ( )
DE (1) DE3137125A1 ( )
FR (1) FR2490493B1 ( )
GB (1) GB2084018A ( )
IT (1) IT1141070B ( )
NL (1) NL8104357A ( )
SE (1) SE459899B ( )
ZA (1) ZA816242B ( )

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
EP1169322B8 (en) 1999-03-08 2006-09-13 Medicure Inc. Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6
EP1196171A2 (en) 1999-07-13 2002-04-17 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
EP1210117A2 (en) * 1999-08-24 2002-06-05 Medicure International Inc. Compositons for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
DE60133323T2 (de) 2000-02-29 2009-03-05 Medicure International Inc. Cardioprotektive Phosphonate
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
JP2003528146A (ja) 2000-03-28 2003-09-24 メディキュア インターナショナル インコーポレイテッド 脳血管疾患の治療
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
ATE364595T1 (de) 2000-07-07 2007-07-15 Medicure Int Inc Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
EP1817288A4 (en) 2004-10-28 2009-08-26 Medicure Int Inc DUAL ANTIPLÄTTCHEN / ANTIKOAGULANS PYRIDOXINANALOGE
US7459468B2 (en) 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
WO2009073944A1 (en) * 2007-12-12 2009-06-18 Iovate T. & P. Inc. USE OF PYRIDOXINE α-HYDROXYISOCAPROATE TO REDUCE METABOLIC ACIDOSIS AND AMMONIA ACCUMULATION
US20090156648A1 (en) * 2007-12-12 2009-06-18 Iovate T. & P. Inc. Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (HICA)
US10278327B2 (en) 2014-05-09 2019-05-07 Shakespeare Company, Llc Trimmer head for use with line and blades
US20210369750A1 (en) * 2018-10-24 2021-12-02 Ponce De Leon Health Designated Activity Company Nicotinamide riboside compositions for healthspan extension

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6453M ( ) * 1967-06-13 1968-11-12
ES360566A1 (es) * 1968-11-22 1970-10-16 Made Labor Sa Un metodo de obtencion de alfa-cetoglutarato de piridoxina y sus derivados.
US3784553A (en) * 1972-01-17 1974-01-08 Made Labor Sa Pyridoxine alpha-ketoglutarate and its derivatives

Also Published As

Publication number Publication date
DE3137125A1 (de) 1982-04-01
FR2490493A1 (fr) 1982-03-26
ZA816242B (en) 1982-08-25
DE3137125C2 ( ) 1989-04-06
CA1177408A (en) 1984-11-06
JPS5782316A (en) 1982-05-22
IT8024827A0 (it) 1980-09-22
FR2490493B1 (fr) 1986-03-07
IT1141070B (it) 1986-10-01
CH655009A5 (it) 1986-03-27
NL8104357A (nl) 1982-04-16
SE459899B (sv) 1989-08-21
GB2084018A (en) 1982-04-07
BE890454A (fr) 1982-01-18
US4361570A (en) 1982-11-30

Similar Documents

Publication Publication Date Title
SE8105561L (sv) Anvendning av pyridoxin-alfa-ketoglutarat vid profylax av hypermjolksyraemi
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
JPH0640904A (ja) 医薬組成物
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
DK330685A (da) Kombinationspraeparat og dets anvendelse
ATE282418T1 (de) Orale verabreichung wirksamer mengen von hyaluronsäure
IL107134A0 (en) Pharmaceutical compositions for the treatment of parkinson's disease
NO166939C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
DK0920865T3 (da) Farmaceutiske sammensætninger indeholdende norastemizol
KR970025615A (ko) 암 전이 억제제
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
DE3162614D1 (en) Dibenzoxazepine derivative, process for preparing the same and pharmaceutical composition comprising the same
BR0015149A (pt) Método e composições para administração de taxanos oralmente a pacientes humanos
ES427079A1 (es) Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7.
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
KR920702225A (ko) 약학 조성물
KR927002224A (ko) 항종양효과증강제 및 항종양제
SU1632428A1 (ru) Способ лечени т желой черепно-мозговой травмы в острый период заболевани
Hyman Anaphylactic shock after therapy with penicillinase
US5128141A (en) Association of physiologically dosed vitamin a and of various active principles having a therapeutical activity
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
FR2380778A1 (fr) Compositions pharmaceutiques contenant des acides oxaniliques substitues ou leurs esters
Knudsen et al. Jarisch-Herxheimer reaction in the treatment of early syphilis with penicillin and bismuth-arsphenamine.
Craig The place of potentiated trimethoprim in the therapy of diseases of the skin in dogs and cats
Alergant Therapy of lymphogranuloma inguinale with 7218

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8105561-8

Effective date: 19920408

Format of ref document f/p: F